Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-1.23%
SPX
-1.60%
IXIC
-2.24%
FTSE
-0.70%
N225
-0.66%
AXJO
-0.92%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

MDpanel Partners with Integra Lifesciences to Enhance Medical Evaluation Services in Canada

publisher logo
Cashu
2 days ago
Cashu TLDR
  • Integra Medical Consulting partners with MDpanel to improve medical evaluation services across North America.
  • The collaboration aims to enhance report quality and operational efficiency in medical evaluations.
  • Integra's expertise and network will help MDpanel streamline the evaluation process for timely, reliable assessments.
iart Logo
IART
Integra Lifesciences Holdings
-6.39%

MDpanel Partners with Integra Medical Consulting to Enhance Medical Evaluation Services in Canada

MDpanel recently announces a strategic alliance with Integra Medical Consulting, a distinguished independent medical evaluation (IME) provider located in Vancouver, British Columbia. This partnership signifies MDpanel's second expansion into Canada and its inaugural venture into conducting comprehensive IMEs. By combining forces, the two organizations aim to elevate access to quality medical opinions across North America, a critical advancement in the healthcare landscape. Jason Erdell, CEO of MDpanel, expresses enthusiasm for this collaboration, emphasizing the potential to broaden their platform's reach while leveraging Integra’s established expertise in the field.

Integra Medical Consulting, with nearly ten years of experience, is recognized for its extensive network of medical professionals and a commitment to delivering objective, high-touch service. This collaboration is designed to benefit a diverse clientele that includes government agencies, legal professionals, insurers, and employers. The partnership focuses on enhancing report quality, operational efficiency, and overall client experience—a significant goal in an industry where the accuracy and reliability of medical evaluations can profoundly impact legal and insurance outcomes. Erica Enstrom, Integra's CEO, underscores the importance of the partnership in providing essential tools and infrastructure necessary for sustainable growth and maintaining high service standards.

The integration of Integra's local expertise with MDpanel's technology-driven platform positions the partnership to deliver a consistent, credible, and efficient experience for clients seeking medical opinions. By harnessing Integra's physician network, MDpanel aims to streamline the evaluation process, which is essential for ensuring timely and accurate assessments. The collaboration also sets the stage for MDpanel to further establish itself as a prominent provider of expert medical opinions in the U.S. and beyond, ultimately supporting a growing need for reliable medical evaluations in an increasingly complex healthcare environment.

In addition to the partnership's operational objectives, legal advisors play a crucial role in facilitating this collaboration. MDpanel enlists the expertise of Calfee, Halter & Griswold LLP and Cassels Brock & Blackwell LLP, while TechStrat serves as the exclusive M&A advisor to Integra. This strategic alliance not only enhances service delivery but also symbolizes a significant step forward in the integration of technology and medical evaluation services, which is essential for the future of healthcare in North America.

For further insights and updates, interested parties can visit MDpanel’s website at www.mdpanel.com.

The content provided here is for informational purposes only and should not be considered financial or investment advice. Investing in stocks carries risks, including potential loss of principal. Always do your own research and consult with a licensed financial advisor before making any investment decisions. We are not responsible for any losses or damages resulting from your use of this information.

More News

Feature in Progress
This section is under development. Check back soon for updates!